Schering Goes After Impax Over Vytorin ANDA
Schering Corp. and MSP Singapore Co. LLC have accused Impax Laboratories Inc. of infringing two patents through its efforts to introduce a generic version of cholesterol drug Vytorin....To view the full article, register now.
Already a subscriber? Click here to view full article